Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia.
Fan BE, Chia YW, Sum CLL, Kuperan P, Chan SSW, Ling LM, Tan GWL, Goh SSN, Wong LH, Lim SP, Lim KGE, Tan HT, Ang MK, Lau SL, Ong KH, Ng J. Fan BE, et al. Among authors: ang mk. J Thromb Thrombolysis. 2020 Aug;50(2):292-297. doi: 10.1007/s11239-020-02165-w. J Thromb Thrombolysis. 2020. PMID: 32474758 Free PMC article. No abstract available.
COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis.
Fan BE, Ng J, Chan SSW, Christopher D, Tso ACY, Ling LM, Young BE, Wong LJL, Sum CLL, Tan HT, Ang MK, Lim GH, Ong KH, Kuperan P, Chia YW. Fan BE, et al. Among authors: ang mk. J Thromb Thrombolysis. 2021 Apr;51(3):663-674. doi: 10.1007/s11239-020-02318-x. Epub 2020 Oct 24. J Thromb Thrombolysis. 2021. PMID: 33098540 Free PMC article.
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.
Fan BE, Ramanathan K, Sum CLL, Christopher D, Chan SSW, Lim GH, Bok CF, Wong SW, Lye DC, Young BE, Lim JY, Lee RM, Lim SP, Tan HT, Ang MK, Lau SL, Kuperan P, Ong KH, Chia YW. Fan BE, et al. Among authors: ang mk. J Thromb Thrombolysis. 2022 Apr;53(3):646-662. doi: 10.1007/s11239-021-02575-4. Epub 2021 Sep 28. J Thromb Thrombolysis. 2022. PMID: 34581945 Free PMC article.
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.
Toh HC, Yang MH, Wang HM, Hsieh CY, Chitapanarux I, Ho KF, Hong RL, Ang MK, Colevas AD, Sirachainan E, Lertbutsayanukul C, Ho GF, Nadler E, Algazi A, Lulla P, Wirth LJ, Wirasorn K, Liu YC, Ang SF, Low SHJ, Tho LM, Hasbullah HH, Brenner MK, Wang WW, Ong WS, Tan SH, Horak I, Ding C, Myo A, Samol J. Toh HC, et al. Among authors: ang mk. Ann Oncol. 2024 Dec;35(12):1181-1190. doi: 10.1016/j.annonc.2024.08.2344. Epub 2024 Sep 4. Ann Oncol. 2024. PMID: 39241963 Free article. Clinical Trial.
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC.
Saw SPL, Low YF, Lai GGY, Chan LL, Wong WKY, Tsui G, Chen OH, Seet AOL, Tan WC, Tan AC, Chan JWK, Teh YL, Tan WL, Ng QS, Ang MK, Kanesvaran R, Lim DWT, Tan DSW, Mok TSK, Li MSC. Saw SPL, et al. Among authors: ang mk. Lung Cancer. 2024 Jul;193:107856. doi: 10.1016/j.lungcan.2024.107856. Epub 2024 Jun 15. Lung Cancer. 2024. PMID: 38889498 Free article.
Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations.
Huang CY, Jiang N, Shen M, Lai GG, Tan AC, Jain A, Saw SP, Ang MK, Ng QS, Lim DW, Kanesvaran R, Tan EH, Tan WL, Ong BH, Chua KL, Anantham D, Takano AM, Lim KH, Tam WL, Sim NL, Skanderup AJ, Tan DS, Rozen SG. Huang CY, et al. Among authors: ang mk. Cancer Res. 2024 Jun 14;84(12):2009-2020. doi: 10.1158/0008-5472.CAN-23-2551. Cancer Res. 2024. PMID: 38587551
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.
Tan AC, Lai GGY, Saw SPL, Chua KLM, Takano A, Ong BH, Koh TPT, Jain A, Tan WL, Ng QS, Kanesvaran R, Rajasekaran T, Kalashnikova E, Renner D, Sudhaman S, Malhotra M, Sethi H, Liu MC, Aleshin A, Lim WT, Tan EH, Skanderup AJ, Ang MK, Tan DSW. Tan AC, et al. Among authors: ang mk. Cancer. 2024 May 15;130(10):1758-1765. doi: 10.1002/cncr.35263. Epub 2024 Feb 29. Cancer. 2024. PMID: 38422026
Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma.
Neo J, Yip PL, Ong EHW, Miao J, Chow WM, Wee JTS, Fong KW, Soong YL, Tan TWK, Tan JSH, Sin SY, Liu J, Loh KS, Tay JK, Ang MK, Tan SH, Lim DWT, Chua MLK. Neo J, et al. Among authors: ang mk. Oral Oncol. 2024 Jan;148:106655. doi: 10.1016/j.oraloncology.2023.106655. Epub 2023 Dec 5. Oral Oncol. 2024. PMID: 38056062 Free article.
77 results